EICHOR
● Completed
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
Condition: Autistic Disorder · Behavioral Symptoms · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
About this study
This study will provide long-term safety data for patients who are taking aripiprazole for up to 1 year. Most patients enrolled in this study will have participated in a short-term study with aripiprazole (CN138-178 \[NCT00332241\] or CN138-179 \[NCT00337571\]).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (55)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Harmonex Neuroscience | Dothan, Alabama, United States | — |
| Southwest Autism Research and Resource Center | Phoenix, Arizona, United States | — |
| Univ of Arizona | Tucson, Arizona, United States | — |
| Clinical Innovations, Inc | Costa Mesa, California, United States | — |
| Peninsula Research Assoc | Rolling Hills Estates, California, United States | — |
| University Of California-Davis Health Science Center | Sacramento, California, United States | — |
| Sharp Mesa Vista Hospital | San Diego, California, United States | — |
| Stanford University School Of Medicine | Stanford, California, United States | — |
| The Children's Hospital | Aurora, Colorado, United States | — |
| Offices of Gregory Marsella, MD, PA | Boca Raton, Florida, United States | — |
| Sarkis Clinical Trials | Gainesville, Florida, United States | — |
+ 43 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00365859